Fingerprint
Dive into the research topics of 'Pembrolizumab in Combination with Radiotherapy for Metastatic Melanoma - Introducing the PERM Trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Pembrolizumab in Combination with Radiotherapy for Metastatic Melanoma - Introducing the PERM Trial
K Yip , A Melcher , K Harrington , Timothy Illidge, J Nobes , A Webster , D Smith , Paul Lorigan, P Nathan , J Larkin
Research output: Contribution to journal › Review article